Elite Pharmaceuticals (OTCMKTS:ELTP) Share Price Crosses Below 200 Day Moving Average – Time to Sell?

Shares of Elite Pharmaceuticals Inc. (OTCMKTS:ELTP) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.56 and traded as low as $0.42. Elite Pharmaceuticals shares last traded at $0.44, with a volume of 267,149 shares traded.

Elite Pharmaceuticals Trading Up 4.3%

The company has a debt-to-equity ratio of 0.06, a quick ratio of 6.34 and a current ratio of 8.04. The stock has a market cap of $473.88 million, a price-to-earnings ratio of 44.04 and a beta of 0.33. The company’s 50 day simple moving average is $0.47 and its two-hundred day simple moving average is $0.56.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.

Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.